Hsin-Han Chang
Overview
Explore the profile of Hsin-Han Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang J, Chang H, Chen T, Tsai W, Huang W, Lo C, et al.
Eur J Pharmacol
. 2023 Nov;
960:176183.
PMID: 37953156
No abstract available.
2.
Yang J, Chen T, Chang H, Tsai Y, Tsai W, Huang W, et al.
Eur J Pharmacol
. 2022 Nov;
938:175411.
PMID: 36436590
Glioblastoma multiforme (GBM) is a deadly brain malignancy, and current therapies offer limited survival benefit. The phytosterol guggulsterone (GS) has been shown to exhibit antitumor efficacy. This study aimed to...
3.
Chang H, Lin Y, Chen T, Tsai Y, Lai C, Tsai W, et al.
Cancers (Basel)
. 2022 Nov;
14(22).
PMID: 36428804
Glioblastoma is believed to be one of the most aggressive brain tumors in the world. ONX-0914 (PR957) is a selective inhibitor of proteasome subunit beta type-8 (PSMB8). Previous studies have...
4.
Lai C, Tsai Y, Tsai W, Chen T, Chang H, Changchien C, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139556
Bladder cancer is one of the most prevailing cancers worldwide. Although treatments for urothelial carcinoma have improved, the rate of recurrence observed in the clinic is still high. The aim...
5.
Tsai C, Changchien C, Chen Y, Lai C, Chen T, Chang H, et al.
Cancers (Basel)
. 2022 Jun;
14(11).
PMID: 35681743
Lung cancer-related pleural fluid (LCPF) presents as a common complication with limited treatment. Beyond its function in lipid digestion, bile acid was identified as a potent carcinogen to stimulate tumor...
6.
Lai C, Wang H, Chang H, Tsai Y, Tsai W, Lee C, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563650
(1) Background: Bladder cancer is a malignant tumor mainly caused by exposure to environmental chemicals, with a high recurrence rate. NR1H4, also known as Farnesoid X Receptor (FXR), acts as...
7.
Tsai C, Changchien C, Chen Y, Chang H, Tsai W, Wang Y, et al.
Cells
. 2022 Mar;
11(5).
PMID: 35269438
Impaired wound healing is an ongoing issue that cancer patients undergoing chemotherapy or radiotherapy face. Our previous study regarding lung-cancer-associated pleural fluid (LCPF) demonstrated its propensity to promote endothelial proliferation,...
8.
Lin C, Chang H, Lai C, Wang H, Tsai W, Tsai Y, et al.
Int J Mol Sci
. 2022 Feb;
23(4).
PMID: 35216267
Bladder cancer (BC) has a high recurrence rate worldwide. The aim of this study was to evaluate the role of fatty acid binding protein 6 (FABP6) in proliferation and migration...
9.
Pai F, Huang H, Tsai Y, Tsai W, Cheng Y, Chang H, et al.
Cells
. 2021 Oct;
10(10).
PMID: 34685761
Malignant glioma is one of the most lethal cancers with rapid progression, high recurrence, and poor prognosis in the central nervous system. Fatty acid-binding protein 6 (FABP6) is a bile...
10.
Chen W, Lin Y, Changchien C, Chen Y, Chang H, Tsai W, et al.
Biomedicines
. 2021 Oct;
9(10).
PMID: 34680445
Malignant-associated pleural fluid (MAPF) represented an unsolved problem in advanced lung cancer. Our previous work characterized increased pleural angiogenesis in lung adenocarcinoma and the propensity of MAPF on endothelial angiogenesis....